in this randomized double-blind and placebo controlled trial of 6 months ' prophylaxis with acyclovir ( acv ) in 42 bone marrow transplant ( bmt ) recipients , patients receiving acv had fewer herpes simplex virus ( hsv ) and varicella-zoster virus ( vzv ) infections during the prophylaxis compared to the placebo treated patients ( p less than 0.05 ) .
C0001367
acv
C0008049
varicella-zoster